SCHEMBL664145

SCHEMBL664145

Cc1c(O)c(C)c2c(c1O)CC(=O)C(c1ccccc1)O2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.39
POLB P06746 3/20 0.37
ABCG2 Q9UNQ0 2/20 0.37
MAPT P10636 2/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
KDM4E B2RXH2 1/20 0.37
CYP19A1 P11511 5/20 0.37
ABCB1 P08183 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
ALDH1A1 P00352 3/20 0.33
KMT2A Q03164 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CA2 P00918 1/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
PABPC1 P11940 1/20 0.33
APEX1 P27695 1/20 0.33
RECQL P46063 1/20 0.33
EIF4H Q15056 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11120384 0.86 MAOA (0.34) POLBMAPTKDM4EALDH1A1MAOA
SCHEMBL664362 0.86 CYP19A1 (0.46) POLBABCG2MAPTCRHBPCRHR2
SCHEMBL29085240 0.86 CYP19A1 (0.47) ALOX5POLBABCG2MAPTCRHBP
SCHEMBL11119917 0.84 LMNA (0.40) POLBMAPTCYP19A1ALDH1A1KMT2A
SCHEMBL10606553 0.84 AR (0.35) POLBABCG2MAPTCRHBPCRHR2
SCHEMBL1201689 0.83 KDM4E (0.40) ALOX5POLBMAPTKDM4ECYP19A1
SCHEMBL29204371 0.80 CYP19A1 (0.42) POLBABCG2MAPTKDM4ECYP19A1
SCHEMBL11121382 0.79 CDK1 (0.47) MAPTGAA
SCHEMBL661409 0.79 CYP19A1 (0.53) POLBABCG2MAPTCYP19A1ABCB1
SCHEMBL1200431 0.78 PTPN1 (0.45) ALOX5POLBCYP19A1KMT2ACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103585194-A Application of Aleuritopteris argentea Fee extract in preparation of drugs treating AIDS JINAN XINGYI MED TECH CO LTD 2014-02-19 CN claimed
CN-103585192-A Preparation method and application of Aleuritopteris argentea Fee extract JINAN XINGYI MED TECH CO LTD 2014-02-19 CN claimed
CN-103585193-A Application of Aleuritopteris argentea Fee extract in preparation of drugs treating leukemia JINAN XINGYI MED TECH CO LTD 2014-02-19 CN claimed
CN-103585196-A Application of silvery aleuritopteris herb extract in preparation of anticancer drugs JINAN XINGYI MED TECH CO LTD 2014-02-19 CN claimed
CN-103585196-B Aleuritopteris argentea (Gmel.) Fee extract is preparing the application in cancer therapy drug ZHOU JIEHUA (CN) 2016-01-20 CN disclosed
CN-103585193-B The application of Aleuritopteris argentea (Gmel.) Fee extract in preparation treatment leukemia medicament BAI XIAOYING (CN) 2016-01-20 CN disclosed
CN-103585192-B A kind of preparation method of Aleuritopteris argentea (Gmel.) Fee extract and application thereof YU LI (CN) 2015-10-28 CN disclosed
CN-103585194-B The application of Aleuritopteris argentea (Gmel.) Fee extract in preparation treatment AIDS-treating medicine SUN CHENGYONG (CN) 2015-10-28 CN disclosed
CN-103585194-A Application of Aleuritopteris argentea Fee extract in preparation of drugs treating AIDS JINAN XINGYI MED TECH CO LTD 2014-02-19 CN disclosed
CN-103585193-A Application of Aleuritopteris argentea Fee extract in preparation of drugs treating leukemia JINAN XINGYI MED TECH CO LTD 2014-02-19 CN disclosed
CN-103585192-A Preparation method and application of Aleuritopteris argentea Fee extract JINAN XINGYI MED TECH CO LTD 2014-02-19 CN disclosed
CN-103585196-A Application of silvery aleuritopteris herb extract in preparation of anticancer drugs JINAN XINGYI MED TECH CO LTD 2014-02-19 CN disclosed
US-20120046353-A1 CLEISTOCALYX OPERCULATUS-DERIVED COMPOUNDS HAVING INHIBITORY ACTIVITIES AGAINST AVIAN AND SWINE INFLUENZA VIRUSES OR NOVEL INFLUENZA VIRUS CHOONG ANG VACCINE LAB. (KR) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046353-A1 CLEISTOCALYX OPERCULATUS-DERIVED COMPOUNDS HAVING INHIBITORY ACTIVITIES AGAINST AVIAN AND SWINE INFLUENZA VIRUSES OR NOVEL INFLUENZA VIRUS PIGS, CLEC4M, ENGASE ALOX5 2840/4885POLB 3306/4885ABCG2 1926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.